GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genoray Co Ltd (XKRX:122310) » Definitions » Days Sales Outstanding

Genoray Co (XKRX:122310) Days Sales Outstanding : 36.63 (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Genoray Co Days Sales Outstanding?

Genoray Co's average Accounts Receivable for the three months ended in Mar. 2024 was ₩10,054 Mil. Genoray Co's Revenue for the three months ended in Mar. 2024 was ₩25,045 Mil. Hence, Genoray Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 36.63.

The historical rank and industry rank for Genoray Co's Days Sales Outstanding or its related term are showing as below:

XKRX:122310' s Days Sales Outstanding Range Over the Past 10 Years
Min: 31.02   Med: 56.27   Max: 69.87
Current: 31.02

During the past 13 years, Genoray Co's highest Days Sales Outstanding was 69.87. The lowest was 31.02. And the median was 56.27.

XKRX:122310's Days Sales Outstanding is ranked better than
90% of 220 companies
in the Medical Diagnostics & Research industry
Industry Median: 69.44 vs XKRX:122310: 31.02

Genoray Co's Days Sales Outstanding declined from Mar. 2023 (38.28) to Mar. 2024 (36.63).


Genoray Co Days Sales Outstanding Historical Data

The historical data trend for Genoray Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genoray Co Days Sales Outstanding Chart

Genoray Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 66.00 69.87 60.18 51.12 39.55

Genoray Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 38.28 29.23 33.26 29.87 36.63

Competitive Comparison of Genoray Co's Days Sales Outstanding

For the Diagnostics & Research subindustry, Genoray Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genoray Co's Days Sales Outstanding Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Genoray Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Genoray Co's Days Sales Outstanding falls into.



Genoray Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Genoray Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (9376.519 + 11837.173) / 2 ) / 97897.441*365
=10606.846 / 97897.441*365
=39.55

Genoray Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding (Q: Mar. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Mar. 2024 )) / count ) / Revenue (A: Mar. 2024 )*Days in Period
=( (11837.173 + 8271.74) / 2 ) / 25045.426*365 / 4
=10054.4565 / 25045.426*365 / 4
=36.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genoray Co  (XKRX:122310) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Genoray Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Genoray Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Genoray Co (XKRX:122310) Business Description

Traded in Other Exchanges
N/A
Address
No. 512, 560, Dunchon-daero, Jungwon-gu, Gyeonggi-do, Seongnam-si, KOR, 462-716
Genoray Co Ltd manufactures and sells medical and dental systems in South Korea. The company has developed the 3DCT software for medical and dental applications and developed innovative 3D software for dentistry. The product portfolio includes OSCAR prime, ZEN-7000, MX-600, PORT-X II, PORT-X IV, and PAPAYA.

Genoray Co (XKRX:122310) Headlines

No Headlines